Best sale Peptide Octreotide

Details:

Basic Information:
CAS No 83150-76-9
Sequence
Purity (HPLC)98.0%min.
Molecular Formula C49H66N10O10S2
Molecular Weight 1019.28
Appearance White powder
Single Impurity (HPLC)1.0%max
Amino Acid Composition± 10% of theoretical
Peptide Content (N%)≥ 80.0%
Water Content(Karl Fischer)≤ 7.0%
Acetate Content(HPIC)≤ 12.0%
Specific Rotation (20/D) -45.0~-50.0° (c=0.5 95%HAc)
MS (ESI)Consistent
Mass Balance 95.0~105.0%
Description:
Octreotide has also been used off-label for the treatment of severe, refractory diarrhea from other causes. It is used in toxicology for the treatment of prolonged recurrent hypoglycemia after sulfonylurea and possibly meglitinides overdose. It has also been used with varying degrees of success in infants with nesidioblastosis to help decrease insulin hypersecretion.
Octreotide has been used experimentally to treat obesity, particularly obesity caused by lesions in the hunger and satiety centers of the hypothalamus, a region of the brain central to the regulation of food intake and energy expenditure. The circuit begins with an area of the hypothalamus, the arcuate nucleus, that has outputs to the lateral hypothalamus and ventromedial hypothalamus (VMH), the brain's feeding and satiety centers, respectively.The VMH is sometimes injured by ongoing treatment for acute lymphoblastic leukemia (ALL) or surgery or radiation to treat posterior cranial fossa tumors.

APPLICATION

1.Octreotide has also been used off-label for the treatment of severe, refractory diarrhea from other causes. It is used in toxicology for the treatment of prolonged recurrent hypoglycemia after sulfonylurea and possibly meglitinides overdose. It has also been used with varying degrees of success in infants with nesidioblastosis to help decrease insulin hypersecretion.

2.Octreotide has been used experimentally to treat obesity, particularly obesity caused by lesions in the hunger and satiety centers of the hypothalamus, a region of the brain central to the regulation of food intake and energy expenditure.The circuit begins with an area of the hypothalamus, the arcuate nucleus, that has outputs to the lateral hypothalamus (LH) and ventromedial hypothalamus (VMH), the brain's feeding and satiety centers, respectively.The VMH is sometimes injured by ongoing treatment for acute lymphoblastic leukemia (ALL) or surgery or radiation to treat posterior cranial fossa tumors.